Back | Next |
home / stock / hrtx / hrtx message board
Subject | By | Source | When |
---|---|---|---|
$HRTX bullish 19.34 | stocktrademan | investorshub | 09/16/2016 4:33:24 PM |
slow and steady (ish) climb out of these | r2g2 | investorshub | 09/08/2016 7:41:03 PM |
Here we go | Jumpinjackas | investorshub | 08/11/2016 4:50:43 PM |
This should run disputed these pull backs. | pleeb01 | investorshub | 08/11/2016 1:14:38 AM |
$23s now | ClearlyStocks | investorshub | 08/10/2016 1:24:16 PM |
FDA approval. Expect 20%+ returns | ClearlyStocks | investorshub | 08/10/2016 12:58:54 PM |
Whats In The Latest Heron Therapeutics Data? | venturecapp | investorshub | 08/02/2016 5:50:56 PM |
At a loss for words here. Wtf. | $TRIG$ | investorshub | 08/02/2016 4:27:16 AM |
GREAT DAY YESTERDAY | Tidal~Gains~!! | investorshub | 07/28/2016 12:42:31 PM |
I'm excited to see the promised results!! | Tidal~Gains~!! | investorshub | 07/27/2016 12:50:41 PM |
Big week coming here! Load the boat | Tidal~Gains~!! | investorshub | 07/27/2016 12:45:35 PM |
Buckle up ladies and gents.... It's mid July!!! | pleeb01 | investorshub | 07/17/2016 11:27:31 PM |
Andrew, you know it's coming | Jumpinjackas | investorshub | 06/24/2016 9:08:37 PM |
Huh | RoleA420 | investorshub | 06/24/2016 8:53:10 PM |
Crl | Jumpinjackas | investorshub | 06/24/2016 8:36:31 PM |
Dunno | IPO$ | investorshub | 06/16/2016 4:59:58 PM |
Why such a drop today? | RoleA420 | investorshub | 06/16/2016 4:25:03 PM |
Heron Therapeutics, Inc. (NASDAQ: $HRTX), announced today that | IPO$ | investorshub | 06/06/2016 5:44:53 PM |
Not yet | Jumpinjackas | investorshub | 05/23/2016 11:21:06 PM |
Are we there yet? :-) | rule_rationale | investorshub | 05/20/2016 7:58:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 30, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company...
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System PR Newswire SAN DIEGO , July 15, 2024 /PRNewswire/ -- Heron Therapeutics, Inc....
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...